Concurrent chemoradiation in advanced cervical cancer.

[1]  J. Pringle,et al.  Concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after radical surgery. , 1987, Gynecologic oncology.

[2]  R. Ginsberg,et al.  Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  B. Cummings,et al.  Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy , 1984, Cancer.

[4]  J. Herman,et al.  Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study. , 1984, International journal of radiation oncology, biology, physics.

[5]  M. Friedlander,et al.  The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study. , 1984, Gynecologic oncology.

[6]  T. Prempree.  Parametrial implant in stage III B cancer of the cervix III. A five‐year study , 1983, Cancer.

[7]  J. Byfield,et al.  Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays. , 1982, International journal of radiation oncology, biology, physics.

[8]  G H Fletcher,et al.  Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. , 1982, International journal of radiation oncology, biology, physics.

[9]  S. Rockwell,et al.  Combination therapy with radiation and mitomycin C: preliminary results with EMT6 tumor cells in vitro and in vivo. , 1979, International journal of radiation oncology, biology, physics.

[10]  Y. Nakajima,et al.  Enhancement of mammalian cell killing by 5-fluorouracil in combination with X-rays. , 1979, Cancer research.